Methicillin Resistant Staphylococcus aureus (MRSA) News and Research

RSS
Methicillin-resistant Staphylococcus aureus (MRSA) is a type of bacteria that is resistant to certain antibiotics. These antibiotics include methicillin and other more common antibiotics such as oxacillin, penicillin and amoxicillin. Staph infections, including MRSA, occur most frequently among persons in hospitals and healthcare facilities (such as nursing homes and dialysis centers) who have weakened immune systems.

MRSA infections that occur in otherwise healthy people who have not been recently (within the past year) hospitalized or had a medical procedure (such as dialysis, surgery, catheters) are known as community-associated (CA)-MRSA infections. These infections are usually skin infections, such as abscesses, boils, and other pus-filled lesions.
Scientists identify novel way of synthesising promising new antibiotic

Scientists identify novel way of synthesising promising new antibiotic

New research shows copper can destroy MRSA in touch contamination

New research shows copper can destroy MRSA in touch contamination

Discovery takes researchers one step closer to preventing C. diff

Discovery takes researchers one step closer to preventing C. diff

Paratek initiates Omadacycline phase 3 clinical study in community acquired bacterial pneumonia (CABP)

Paratek initiates Omadacycline phase 3 clinical study in community acquired bacterial pneumonia (CABP)

Cleaning patient rooms with combination of chemicals and UV light cuts transmission of superbugs

Cleaning patient rooms with combination of chemicals and UV light cuts transmission of superbugs

Researchers demonstrate successful eradication of multi-resistant bacteria from stables

Researchers demonstrate successful eradication of multi-resistant bacteria from stables

Duke specialist offers infection control measures to maintain health of pro football players

Duke specialist offers infection control measures to maintain health of pro football players

Daily CHG bathing protocol for pediatric patients reduces bloodstream infections by 59%: Study

Daily CHG bathing protocol for pediatric patients reduces bloodstream infections by 59%: Study

Basilea announces UK launch of broad-spectrum Cephalosporin Zevtera for first-line treatment of pneumonia

Basilea announces UK launch of broad-spectrum Cephalosporin Zevtera for first-line treatment of pneumonia

DigiPath, Euphoria partner to set highest medical marijuana patient safety and education standards

DigiPath, Euphoria partner to set highest medical marijuana patient safety and education standards

Bathing patients in common hospital soap can reduce MRSA contamination

Bathing patients in common hospital soap can reduce MRSA contamination

Rising shortages of key antibiotics raise serious concerns about effects on patient care

Rising shortages of key antibiotics raise serious concerns about effects on patient care

New UV light method could help stop spread of hospital superbugs

New UV light method could help stop spread of hospital superbugs

Infectious diseases experts release new guidance to avoid infections during hospital visits

Infectious diseases experts release new guidance to avoid infections during hospital visits

Restrooms are no more healthy, unhealthy than your home

Restrooms are no more healthy, unhealthy than your home

Vancomycin drug still effective in treating Staphylococcus aureus bloodstream infections

Vancomycin drug still effective in treating Staphylococcus aureus bloodstream infections

Columbia Nursing researcher suggests ways to prevent nursing home infections

Columbia Nursing researcher suggests ways to prevent nursing home infections

Antibiotic stewardship programs reduce hospital readmissions due to infection

Antibiotic stewardship programs reduce hospital readmissions due to infection

MRSA superbug control policies in hospitals lack evidence, say infectious disease experts

MRSA superbug control policies in hospitals lack evidence, say infectious disease experts

TAXIS acquires novel antimicrobial drug candidates from Biota

TAXIS acquires novel antimicrobial drug candidates from Biota